Cesar Augusto Santa-Maria
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 9
- Cancer Treatment and Pharmacology 7
- PARP inhibition in cancer therapy 5
- Cancer Risks and Factors 3
- Cancer survivorship and care 3
- HER2/EGFR in Cancer Research 3
-
- Cancer Genomics and Diagnostics 4
-
- Advanced Breast Cancer Therapies 11
Cesar Augusto Santa-Maria
27 papers receiving 329 citations
Peers
Comparison fields: 5 of 54
- Oncology 247
- Cancer Research 57
- Geriatrics and Gerontology 12
- Clinical Psychology 49
- Pulmonary and Respiratory Medicine 56
Countries citing papers authored by Cesar Augusto Santa-Maria
This map shows the geographic impact of Cesar Augusto Santa-Maria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cesar Augusto Santa-Maria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cesar Augusto Santa-Maria more than expected).
Fields of papers citing papers by Cesar Augusto Santa-Maria
This network shows the impact of papers produced by Cesar Augusto Santa-Maria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cesar Augusto Santa-Maria. The network helps show where Cesar Augusto Santa-Maria may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cesar Augusto Santa-Maria, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 10 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 11 | |
| 8 | 2022 | 1 | |
| 9 | 2020 | 94 | |
| 10 | 2020 | 40 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 3 | |
| 13 | 2020 | 8 | |
| 14 | 2017 | 4 | |
| 15 | 2017 | 0 | |
| 16 | 2017 | 12 | |
| 17 | 2016 | 34 | |
| 18 | 2014 | 24 | |
| 19 | 2014 | 5 | |
| 20 | 2013 | 3 |
About Cesar Augusto Santa-Maria
Cesar Augusto Santa-Maria is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 29 papers that have together received 333 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cancer Treatment and Pharmacology (7 papers), PARP inhibition in cancer therapy (5 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Risks and Factors (3 papers), Cancer survivorship and care (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (247 citations), Cancer Research (57 citations) and Geriatrics and Gerontology (12 citations). Cesar Augusto Santa-Maria has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Gerald J. Jerome, Joseph O’Brien, Xianghui Zou, Yueming Zhu, David Gius, Dipali Sharma, Chuang Chen, Xian‐Jin Xie, David Euhus and Xingrui Li. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Future Oncology and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.